0.82 USD
▲+0.03+2.33%
盘后 0.79 -1.41%
2026-08-03
市值
$111.81M
市盈率
—
EPS
-0.29
股息率
—
52 周区间
0.44 – 3.87
成交量
1.12M
Beta
0.80
目标价
7.50
52W 低 0.4452W 高 3.87
价格走势
公司简介
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-105, an anti-TNF-alpha antibody that is in prec...